UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007248
Receipt number R000008543
Scientific Title A study of collecting comprehensive samples for rare intractable skin diseases in human being
Date of disclosure of the study information 2012/02/08
Last modified on 2019/08/15 14:25:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of collecting comprehensive samples for rare intractable skin diseases in human being

Acronym

A study of collecting comprehensive samples

Scientific Title

A study of collecting comprehensive samples for rare intractable skin diseases in human being

Scientific Title:Acronym

A study of collecting comprehensive samples

Region

Japan


Condition

Condition

pemphigus, pustular psoriasis, epidermolysis bullosa hereditaria, congenital ichthyosiform erythroderma, neurofibromatosis(type1,2), xeroderma pigmentosum, tuberous sclerosis

Classification by specialty

Dermatology Adult Child

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Seven diseases (pemphigus, pustular psoriasis, epidermolysis bullosa hereditaria, congenital ichthyosiform erythroderma, neurofibromatosis (type 1 and 2), xeroderma pigmentosum, and tuberous sclerosis) be studied, and a permanent system will be developed to manage biological samples of rare and intractable skin diseases under strict quality control. Not only biological samples of rare and intractable skin diseases will be stored to provide storage of samples for genetic analyses, but the registry will also contain patients' clinical information. In order to achieve its purpose, a dermatologist familiar with these diseases is needed to operate the consolidated clinical information and biological sample collection. While seeking close cooperation with a study group performing research on neurocutaneous syndromes and a team doing research on rare intractable skin diseases, which is the parent body, joint research on the diagnosis and treatment of refractory rare skin diseases in Japan will be facilitated by improving the management of a valid collection of biological samples. Biological samples (gene, serum, skin tissue) will be collected from patients with target diseases, and an appropriate management structure will be developed that will contribute to the administration of health care in Japan. This collection system of biological samples will provide a permanent basis, in order to develop innovative diagnostic methods and therapies for intractable skin diseases.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

This study is intended to produce a framework for centralized projects involving a Research Resources Bank for intractable diseases for the long-term that will be effectively used for research studies on incurable skin diseases using samples donated by patients.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

The inclusion criteria for the patients are
1) Patient (male and female) under the age of 75 years at the time of obtaining informed consent
2) Patients who meet any of the following three diagnostic criteria
(1) Diagnostic criteria proposed by a research group of the intractable rare skin diseases
(2) Diagnostic criteria proposed by a research group of the neurocutaneous syndrome
(3) Diagnostic guidelines proposed by the Japanese Dermatological Association
3) Patient receives an adequate explanation prior to participation in this study and voluntarily gives informed consent: if the patient age is under the age of 20 years, informed consent is obtained from the patient's parents or a legal representative
4) Hospital outpatient and inpatient

Key exclusion criteria

Patients who fall under the following are not included in this study:
1) 75 years of age or more at diagnosis
2) Patients who do not have health insurance
3) HBs antigen-positive
4) Patients with unstable angina
5) Patients with severe liver damage (AST(GOT) or ALT(GPT) > 100 IU/L)
6) Patients with severe renal damage (serum creatinine > 2.0 mg/dL or BUN > 25 mg/dL)
7) Patients who are pregnant or have a possibility of pregnancy
8) Lactating women
9) Others deemed inappropriate as subjects for the research by the doctor conducting the research
10) Neurofibromatosis (1) patients with only cafe au lait spots

Target sample size

584


Research contact person

Name of lead principal investigator

1st name Yutaka
Middle name
Last name Shimomura

Organization

Yamaguchi university graduate school of medicine, dermatology

Division name

dermatology

Zip code

755-8505

Address

1-1-1,MinamiKogushi,Ube City,Yamaguchi Prefecture,Japan 755-8505

TEL

0836-22-2271

Email

yshimo@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Yutaka
Middle name
Last name Yutaka Shimomura

Organization

Yamaguchi university graduate school of medicine, department of dermatology

Division name

dermatology

Zip code

755-8505

Address

1-1-1,MinamiKogushi,Ube City,Yamaguchi Prefecture,Japan 755-8505

TEL

0836-22-2271

Homepage URL


Email

yshimo@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi university graduate school of medicine, department of dermatology

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi university graduate school of medicine, department of dermatology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University Hospital

Address

1-1-1,MinamiKogushi,Ube City,Yamaguchi Prefecture,Japan

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

33

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 08 Month 01 Day

Date of IRB

2011 Year 08 Month 01 Day

Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information

We have finished the study on March 31, 2019.


Management information

Registered date

2012 Year 02 Month 08 Day

Last modified on

2019 Year 08 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008543


Research Plan
Registered date File name
2018/02/12 final-下村-加筆-【5版】H23-33-4 実施計画書.doc

Research case data specifications
Registered date File name
2018/02/12 仕様書.jpg

Research case data
Registered date File name
2018/02/12 症例.jpg